Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes

INTRODUCTION: It remains unknown whether dipeptidyl peptidase-4 (DPP-4) inhibitors improve early-phase insulin secretion in Japanese patients with type 2 diabetes (T2D), a disease characterized by impaired insulin secretion. We investigated the changes in insulin secretion before and after treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Rika, Fukui, Tomoyasu, Hayashi, Toshiyuki, Osamura, Anna, Ohara, Makoto, Hara, Noriko, Higuchi, Akiko, Yamamoto, Takeshi, Hirano, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561050/
https://www.ncbi.nlm.nih.gov/pubmed/26224337
http://dx.doi.org/10.1007/s40268-015-0096-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561050/
https://www.ncbi.nlm.nih.gov/pubmed/26224337
http://dx.doi.org/10.1007/s40268-015-0096-6

Ejemplares similares